Veradigm (NASDAQ:MDRX) Trading Down 10.7% – Should You Sell?

by · The Cerbat Gem

Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares traded down 10.7% on Monday . The stock traded as low as $4.55 and last traded at $4.55. 1,269 shares were traded during trading, a decline of 99% from the average daily volume of 153,126 shares. The stock had previously closed at $5.0950.

Veradigm Stock Down 1.9%

The company has a market capitalization of $611.50 million, a price-to-earnings ratio of 23.25 and a beta of 0.53. The stock’s fifty day moving average price is $4.85 and its 200-day moving average price is $4.67.

About Veradigm

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Read More